INTRODUCTION
In the context of epidemics and pandemics, in November 2019, an outbreak
of respiratory disease caused by the new coronavirus (SARS-CoV-2), was
detected in the city of Wuhan, China [1]. In March 2020, the new
coronavirus (COVID-19) spread throughout the world causing respiratory
disease and deaths especially in risk groups such as the elderly
pregnant women, immunocompromised people, and others [1].
The World Health Organization (WHO) declared, on January 30, 2020, that
the disease outbreak caused by COVID-19 constitutes a Public Health The emergency of International Importance - the highest level of alert in
the Organization, as provided for in the Regulations International
Health. On March 11, 2020, COVID-19 has characterized by WHO as a
pandemic [2].
About 6,287,771 cases of COVID-19 (93,246 new about the previous day)
and 379,941 deaths (3,621 new concerning the previous day) were
confirmed worldwide by June 3, 2020 [3]. In the Region of the
Americas, 1,036,155 people who were infected with the new coronavirus
recovered, according to data from June 3, 2020. The Pan American Health
Organization (PAHO) and WHO is providing technical support to Brazil and
other countries, in the preparation and response to the COVID-19
outbreak [4,5].
In Brazil, on January 22, 2020, the Public Health Emergency Operations
Center for COVID-19 was activated, a strategy provided for in the
National Public Health Emergency Response Plan of the Ministry of Health
(MS). Thus, the Ministry of Health established a structured document
based on existing actions for notification, registration, investigation,
management, and adoption of preventive measures, in analogy to the
accumulated knowledge about SARS-CoV-2 and the Influenza Treatment
Protocol: 2017 of the MS [6].
The recommendations are also guided by the Covid-19 Expert Consensus for
Clinical Management, held on March 10 and 11, 2020, at the headquarters
of the Pan American Health Organization / World Health Organization
(PAHO / WHO ) in Brasilia, when national and international experts were
gathered for discussion and deepening on the subject [8-10].
In this context, Severe Acute Respiratory Syndrome (SARS) (Severe Acute
Respiratory Syndrome - SARS) is a severe acute respiratory disease
caused by SARS-CoV. SARS is much more drastic than other coronavirus
infections [11]. SARS is an influenza-like illness that occasionally
causes severe progressive respiratory failure. SARS-CoV was first
detected in Guangdong, China, in November 2002 and subsequently spread
to more than 30 countries [12]. SARS-CoV is transmitted from person
to person by close personal contact. It believed to transmitted more
readily by respiratory droplets produced when an infected person coughs
or sneezes. The diagnosis of SARS is clinical, and treatment is
supportive [13].
Therefore, this study presented through a systematic review the
considerations about the actions for notification, registration,
investigation, management, and adoption of preventive measures on
SARS-CoV-2 in Severe Acute Respiratory Syndrome (SARS).